Skip to content
2000
Volume 2, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML
Preview this article:
Preview Magnify

There is no abstract available.

© 2021 Bentham Science Publishers
© 2021 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0250688201999201120113151
2020-11-20
2025-09-07

  • From This Site

    /content/journals/nemj/10.2174/0250688201999201120113151
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/2/1/NEMJ-2-1-20.html?itemId=/content/journals/nemj/10.2174/0250688201999201120113151&mimeType=html&fmt=ahah

References

  1. PanH. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. WHO Solidarity trial consortium.N. Engl. J. Med.2020
     [Google Scholar]
  2. PasquiniZ. MontaltiR. TemperoniC. CanovariB. ManciniM. TempestaM. PimpiniD. ZalloccoN. BarchiesiF. Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU.J. Antimicrob. Chemother.202075113359336510.1093/jac/dkaa32132829390
     [Google Scholar]
  3. BeigelJ.H. TomashekK.M. DoddL.E. MehtaA.K. ZingmanB.S. KalilA.C. HohmannE. ChuH.Y. LuetkemeyerA. KlineS. Lopez de CastillaD. FinbergR.W. DierbergK. TapsonV. HsiehL. PattersonT.F. ParedesR. SweeneyD.A. ShortW.R. TouloumiG. LyeD.C. OhmagariN. OhM.D. Ruiz-PalaciosG.M. BenfieldT. FätkenheuerG. KortepeterM.G. AtmarR.L. CreechC.B. LundgrenJ. BabikerA.G. PettS. NeatonJ.D. BurgessT.H. BonnettT. GreenM. MakowskiM. OsinusiA. NayakS. LaneH.C. ACTT-1 Study Group Members Remdesivir for the treatment of Covid-19—preliminary report.N. Engl. J. Med.2020383191813182610.1056/NEJMoa200776432445440
     [Google Scholar]
  4. OlenderS.A. PerezK.K. GoA.S. BalaniB. Price-HaywoodE.G. ShahN.S. WangS. WalunasT.L. SwaminathanS. SlimJ. ChinB. De WitS. AliS.M. Soriano ViladomiuA. RobinsonP. GottliebR.L. TsangT.Y.O. LeeI.H. HaubrichR.H. ChokkalingamA.P. LinL. ZhongL. BekeleB.N. Mera-GilerR. GallantJ. SmithL.E. OsinusiA.O. BrainardD.M. HuH. PhulpinC. EdgarH. Diaz-CuervoH. BernardinoJ.I. Remdesivir for severe COVID-19 versus a cohort receiving standard of care.Clin. Infect. Dis.2020ciaa104110.1093/cid/ciaa104132706859
     [Google Scholar]
  5. Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.Drug Des. Devel. Ther.2020143215322210.2147/DDDT.S261154
     [Google Scholar]
/content/journals/nemj/10.2174/0250688201999201120113151
Loading

  • Article Type:     Letter
Keyword(s): COVID-19; ICU; Remdesivir; Solidarity; Trial; WHO

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test